Patents by Inventor Philip G. Mattingly

Philip G. Mattingly has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100015655
    Abstract: The present disclosure relates to assays and kits for detecting and quantifying damage caused by a parasite in a subject and monitoring the progression of parasitic disease in a subject.
    Type: Application
    Filed: July 17, 2008
    Publication date: January 21, 2010
    Applicant: Abbott Laboratories
    Inventors: Maciej Adamczyk, Roy Jeffrey Brashear, Philip G. Mattingly
  • Patent number: 5616505
    Abstract: Novel tethered hapten intermediates and related conjugates based on 3-phenyl-1-adamantaneacetic acid, as well as methods for making and using such conjugates. Haptens based on the above core structure may be substituted at any position on the phenyl ring, especially at the para position. Using tethered intermediates, immunogens, tracers, solid supports and labeled oligonucleotides are all described; as are methods for using the intermediates to prepare the conjugates, methods of using the conjugates to make and purify anitbodies, as assay tracers, and in nucleic acid hybridization assays. Kits containing haptenated oligonucleotides and anti-hapten conjugates are also described.
    Type: Grant
    Filed: March 24, 1995
    Date of Patent: April 1, 1997
    Assignee: Abbott Laboratories
    Inventor: Philip G. Mattingly
  • Patent number: 5424414
    Abstract: Novel tethered hapten intermediates and related conjugates based on 3- phenyl-1-adamantaneacetic acid, as well as methods for making and using such conjugates. Haptens based on the above core structure may be substituted at any position on the phenyl ring, especially at the para position. Using tethered intermediates, immunogens, tracers, solid supports and labeled oligonucleotides are all described; as are methods for using the intermediates to prepare the conjugates, methods of using the conjugates to make and purify anitbodies, as assay tracers, and in nucleic acid hybridization assays. Kits containing haptenated oligonucleotides and anti-hapten conjugates are also described.
    Type: Grant
    Filed: April 21, 1993
    Date of Patent: June 13, 1995
    Assignee: Abbott Laboratories
    Inventor: Philip G. Mattingly